Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 31% ± 11% | |
lung | 15 studies | 28% ± 11% | |
brain | 13 studies | 30% ± 14% | |
eye | 9 studies | 31% ± 11% | |
kidney | 8 studies | 26% ± 8% | |
intestine | 8 studies | 30% ± 16% | |
liver | 6 studies | 30% ± 18% | |
bone marrow | 5 studies | 25% ± 8% | |
uterus | 5 studies | 36% ± 12% | |
lymph node | 5 studies | 29% ± 9% | |
prostate | 4 studies | 30% ± 9% | |
breast | 4 studies | 28% ± 8% | |
placenta | 3 studies | 25% ± 6% | |
adrenal gland | 3 studies | 26% ± 9% | |
skin | 3 studies | 26% ± 6% | |
thymus | 3 studies | 47% ± 14% | |
adipose | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8734.82 | 1445 / 1445 | 100% | 54.11 | 183 / 183 |
intestine | 100% | 10862.55 | 966 / 966 | 100% | 65.13 | 527 / 527 |
ovary | 100% | 15434.66 | 180 / 180 | 100% | 52.84 | 430 / 430 |
stomach | 100% | 7474.93 | 359 / 359 | 100% | 58.50 | 286 / 286 |
uterus | 100% | 13613.52 | 170 / 170 | 100% | 86.29 | 459 / 459 |
brain | 100% | 8480.50 | 2640 / 2642 | 100% | 89.35 | 705 / 705 |
thymus | 100% | 12904.92 | 653 / 653 | 100% | 84.86 | 604 / 605 |
bladder | 100% | 10078.52 | 21 / 21 | 100% | 64.60 | 503 / 504 |
lung | 100% | 10822.93 | 578 / 578 | 100% | 59.32 | 1151 / 1155 |
prostate | 100% | 9514.65 | 245 / 245 | 100% | 57.16 | 500 / 502 |
breast | 100% | 10369.20 | 459 / 459 | 99% | 63.61 | 1110 / 1118 |
adrenal gland | 100% | 8511.82 | 258 / 258 | 99% | 61.34 | 228 / 230 |
pancreas | 100% | 4779.26 | 328 / 328 | 99% | 56.88 | 176 / 178 |
kidney | 100% | 8447.54 | 89 / 89 | 99% | 55.58 | 888 / 901 |
skin | 100% | 9235.44 | 1809 / 1809 | 98% | 51.57 | 464 / 472 |
liver | 100% | 4311.38 | 226 / 226 | 95% | 28.22 | 387 / 406 |
blood vessel | 100% | 10482.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 69.64 | 29 / 29 |
spleen | 100% | 11473.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.56 | 1 / 1 |
adipose | 100% | 9972.10 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 6414.46 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 6001.27 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 39.56 | 75 / 80 |
peripheral blood | 92% | 5452.07 | 852 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0008380 | Biological process | RNA splicing |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0006396 | Biological process | RNA processing |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HNRNPH3 |
Protein name | Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9) |
Synonyms | HNRPH3 |
Description | FUNCTION: Involved in the splicing process and participates in early heat shock-induced splicing arrest. Due to their great structural variations the different isoforms may possess different functions in the splicing reaction. |
Accessions | ENST00000265866.12 [P31942-1] P31942 ENST00000354695.5 [P31942-2] |